WASHINGTON–(BUSINESS WIRE)–The United States Agency for International Development (USAID) tapped the Clinton Health Access Initiative (CHAI) and the Global Environment & Technology Foundation (GETF) to lead a new coalition to address critical antimicrobial resistance (AMR) challenges faced globally and, most acutely, in low- and middle-income countries.
The new coalition, the Antimicrobial Resistance Access and Stewardship Initiative (AMRASI), is a groundbreaking initiative that will use a sustainable, market-driven approach to address critical gaps in access to diagnostics and antimicrobials while incentivizing their appropriate use in low- and middle-income countries. AMRASI is assembling multi-sectoral stakeholders to design and implement a “proof of concept” pilot to assess the feasibility of a market-based approach that increases access to urgently needed, quality assured, diagnostics and antimicrobials using market shaping instruments, while concurrently promoting stewardship through outcomes-based finance interventions. Following a series of convenings to align on these key pilot areas, the coalition aims to mobilize and launch the targeted pilot to test the model in up to two low- and middle-income countries.
CHAI is supporting the coalition as a core technical partner, leveraging expertise in market-shaping frameworks across therapeutics and diagnostics to inform the pilot design and execution. GETF is serving as the AMRASI Secretariat, supporting the coalition to plan for pilot design in the first half of 2024. The broader AMRASI coalition consists of diagnostics and pharmaceuticals companies, in-country subject matter experts, global health donors, implementing partners, and global AMR groups who will lend their expertise to inform key aspects of the pilot, such as syndrome selection, geographic focus, funding model, pooled procurement operations, and sustainability.
“The AMRASI coalition provides a great opportunity to test innovative strategies to combat AMR and develop learnings that can be shared across the sector. We are excited to work with USAID in pioneering a finance-based model to drive appropriate testing and treatment for bacterial infections,” Dr. David Ripin, Executive Vice President, Access; Chief Scientific Officer, CHAI
About USAID
The United States Agency for International Development (USAID) leads the U.S. Government’s international development and disaster assistance efforts through partnership and investments to save lives, reduce poverty, strengthen democratic governance, and help people emerge from humanitarian crises. USAID’s Global Health Security (GHS) Program and Center for Innovation and Impact (CII) consider antimicrobial resistance a strategic priority to better prepare for and combat global health security threats. To learn more about USAID’s GHS Program please visit www.usaid.gov/global-health/health-areas/global-health-security. To learn more about CII please visit www.usaid.gov/cii.
About Clinton Health Access Initiative
The Clinton Health Access Initiative (CHAI) is a global health organization committed to saving lives and improving health outcomes in low- and middle-income countries by enabling the government and private sector to strengthen and sustain quality health systems. For more information, please visit www.clintonhealthaccess.org.
About Global Environment & Technology Foundation (GETF)
The Global Environment & Technology Foundation (GETF), established in 1988, is a leading 501(c)(3) nonprofit organization with a mission to accelerate sustainable development through partnerships that deliver impact at scale. GETF builds and manages high impact public-private partnerships improving the lives of 14 million people in over 100 countries through water access, sanitation and hygiene, health systems strengthening, entrepreneurship, women’s empowerment, sustainable agriculture and climate resilience. For more information, visit www.getf.org.
Contacts
Corina Milic, Director of Communications, CHAI
Email: cmilic@clintonhealthaccess.org
